Literature DB >> 21252757

Uterine leiomyomas: individualizing the approach to a heterogeneous condition.

Shannon K Laughlin1, Elizabeth A Stewart.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21252757      PMCID： PMC3150866          DOI： 10.1097/AOG.0b013e31820780e3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  60 in total

1.  Pregnancy-related fibroid reduction.

Authors:  Shannon K Laughlin; Amy H Herring; David A Savitz; Andrew F Olshan; Julia R Fielding; Katherine E Hartmann; Donna D Baird
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

2.  Uterine-artery embolization versus surgery for symptomatic uterine fibroids.

Authors:  Richard D Edwards; Jonathan G Moss; Mary Ann Lumsden; Olivia Wu; Lilian S Murray; Sara Twaddle; Gordon D Murray
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

3.  Hysterectomy surveillance in the United States, 1997 through 2005.

Authors:  Ray M Merrill
Journal:  Med Sci Monit       Date:  2008-01

4.  Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production.

Authors:  B S Lee; S B Margolin; R A Nowak
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

5.  Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women.

Authors:  Minnie Malik; John Norian; Desirée McCarthy-Keith; Joy Britten; William H Catherino
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

6.  Why is parity protective for uterine fibroids?

Authors:  Donna Day Baird; David B Dunson
Journal:  Epidemiology       Date:  2003-03       Impact factor: 4.822

7.  Growth of uterine leiomyomata among premenopausal black and white women.

Authors:  Shyamal D Peddada; Shannon K Laughlin; Kelly Miner; Jean-Philippe Guyon; Karen Haneke; Heather L Vahdat; Richard C Semelka; Ania Kowalik; Diane Armao; Barbara Davis; Donna Day Baird
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205

8.  Amenorrhea and resumption of menstruation after uterine artery embolization for fibroids.

Authors:  Tetsuya Katsumori; Toshiyuki Kasahara; Yoko Tsuchida; Taiki Nozaki
Journal:  Int J Gynaecol Obstet       Date:  2008-09-02       Impact factor: 3.561

9.  Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study.

Authors:  P Rosati; C Exacoustòs; S Mancuso
Journal:  J Ultrasound Med       Date:  1992-10       Impact factor: 2.153

10.  New concepts in the treatment of uterine leiomyomas.

Authors:  E A Stewart; R A Nowak
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661
View more
  27 in total

1.  Reassessing hysterectomy.

Authors:  Elizabeth A Stewart; Lynne T Shuster; Walter A Rocca
Journal:  Minn Med       Date:  2012-03

2.  Intraobserver variability in fibroid size measurements: estimated effects on assessing fibroid growth.

Authors:  Malana Moshesh; Shyamal D Peddada; Tracy Cooper; Donna Baird
Journal:  J Ultrasound Med       Date:  2014-07       Impact factor: 2.153

3.  Endometrial Cancer: Hidden Pathology in a Patient with Abnormal Uterine Bleeding and Known Leiomyoma.

Authors:  Trisha Sri; Albert J Steren; Pamela Stratton
Journal:  Gynecol Obstet Invest       Date:  2015-01-27       Impact factor: 2.031

4.  Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.

Authors:  Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Carin Y Smith; Walter A Rocca; Elizabeth A Stewart
Journal:  Menopause       Date:  2018-05       Impact factor: 2.953

5.  Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.

Authors:  V Babashov; S Palimaka; G Blackhouse; D O'Reilly
Journal:  Ont Health Technol Assess Ser       Date:  2015-03-01

6.  Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties.

Authors:  Amanda L Patterson; Jitu W George; Anindita Chatterjee; Tyler J Carpenter; Emily Wolfrum; David W Chesla; Jose M Teixeira
Journal:  Hum Reprod       Date:  2020-01-01       Impact factor: 6.918

7.  A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.

Authors:  D D Baird; T M Saldana; D L Shore; M C Hill; J M Schectman
Journal:  Hum Reprod       Date:  2015-09-25       Impact factor: 6.918

8.  The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women.

Authors:  Saeedeh Salimi; Azam Hajizadeh; Minoo Yaghmaei; Sodabeh Rezaie; Mahnaz Shahrakypour; Batool Teimoori; Mahboube Parache; Anoosh Naghavi; Mojgan Mokhtari
Journal:  Tumour Biol       Date:  2016-06-23

9.  The impact of uterine leiomyomas: a national survey of affected women.

Authors:  Bijan J Borah; Wanda K Nicholson; Linda Bradley; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2013-07-24       Impact factor: 8.661

10.  Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.

Authors:  William H Catherino; Heba M Eltoukhi; Ayman Al-Hendy
Journal:  Semin Reprod Med       Date:  2013-08-09       Impact factor: 1.303
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.